- World’s first CRISPR-based medicine wins approval in U.K. STAT
- UK becomes 1st country to approve gene therapy treatment for sickle cell, thalassemia AOL
- This gene-editing therapy could cure sickle cell disease, and it’s close to FDA approval The Hill
- UK authorises gene therapy for blood disorders in world first Reuters
- Vertex and CRISPR Therapeutics Announce Authorization of the First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), by the United Kingdom MHRA for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta T Business Wire
- View Full Coverage on Google News
Read original article here